Form D · Pharmaceuticals
Cao Pharmaceuticals Inc.15
Webster, TX · CIK 0001784334
Offering snapshot reported Aug 21, 2019 · SEC filing
- Reported sold
- Yet to sell Offering amount: $16M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 21, 2019 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06c, 4a5
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-347058
CZ48 Drug Revenue Interests (see the Offering Memorandum)
See the Issuer's Offering Memorandum.
Source: Form D, filed Aug 21, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Zhisong Cao | Director, Executive, Promoter |
| Doug Coil | Executive |
| Yang Wang | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
17490 Highway 3, Suite B200
Webster, TX, 77598
Webster, TX, 77598